There have been several efforts in the last year to increase the number of women in the life sciences — but it’ll still take 40 years to reach gender parity in the biotech boardrooms, a new report from executive search firm Liftstream says.
A study of 173 biotech companies that went public between 2012 and 2015 showed that 10.9 percent of biotech company boards are women.
A now-infamous cocktail party at the 2016 J.P. Morgan healthcare conference may have gotten the ball rolling on the gender imbalance dialogue — and there have been a few on-the-ground improvements. A training program to encourage women to join life science boards is underway, and an open letter from MassBio and more than 100 others in the industry recently outlined the best practices to achieve gender balance.
About the Author Reprints
